Back HCV Prevention

AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use

Getting tested for hepatitis C virus (HCV) was associated with reduced drug use, especially among those who tested positive, but evenpeople who tested negative saw some reduction, according to study results presented at the AASLD Liver Meeting in October in Washington, DC.

alt

Read more:

AASLD 2017: HCV Infections Are Rising Among HIV+ Gay Men In San Diego

Hepatitis C incidence is increasing among gay and bisexual men living with HIV in San Diego, according to the largest analysis of its kind done in the United States. Study results were presented last week at the 2017 AASLD Liver Meeting in Washington, DC.

alt

Read more:

EACS 2017: High Rate of Hepatitis C Reinfection in German Men Who Have Sex With Men

Around 1 in 7 gay and bisexual men cured of hepatitis C at major treatment centers in Germany have become reinfected since 2014, according to findings from the German Hepatitis C Cohort presented at the 16th European AIDS Conference (EACS 2017) in Milan in October. At least half of these men became reinfected within a year of completing treatment and all reinfections occurred within 18 months.

alt

Read more:

EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort

A systematic policy of test-and-treat cured 99% of men who have sex with men with hepatitis C in the Swiss HIV Cohort during an 8-month period and reduced the prevalence of hepatitis C by almost two-thirds, Dominique Braun of the University Hospital, Zurich, reported at the recent 16th European AIDS Conference (EACS 2017) in Milan.

alt

Read more:

Does Drug Injection Equipment Other than Syringes Transmit Hepatitis C?

Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in the Journal of Infectious Diseases.

alt

Read more: